Baseline kidney function could help identify who is at greater risk for developing chronic kidney disease following cisplatin ...

Imlifidase, an IgG-destroying enzyme, could receive FDA approval in the second half of 2026 and hit peak sales of $306 ...

People with Type 2 diabetes should be concerned with their kidney function, but current testing is woefully insufficient. A ...

Keeping your kidneys healthy is one of the most important things you can do for your overall well-being, yet many Americans ...

Our kidneys play a crucial role in keeping us healthy, filtering waste, balancing fluids, regulating blood pressure, and ...

Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced positive topline results from the US Phase 3 ConfIdeS trial of imlifidase, evaluating 12-month kidney function ...

A meta-analysis of pediatric patients shows the potential promise of this noninvasive biomarker for early diagnosis, risk stratification, and management of nephrotic syndrome.

Proton pump inhibitors (PPIs) do not appear to worsen kidney function compared with the histamine 2 receptor blocker ranitidine based on two measures, a large cohort study from Spain finds. In fact, ...

With more than 25 years of clinical leadership, we’ve developed a connected ecosystem that brings together diabetes ...

A simple regression model based on the pretreatment estimated glomerular filtration rate (eGFR) reliably predicted the ...